Post job

Semma Therapeutics overview

Industry
Health Care
Revenue
Headquarters
Employees
75
Founded in
Organization type
Private
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.
Semma Therapeutics is a small health care company based in Cambridge, MA with only 75 employees and an annual revenue of $34.9M.

Semma Therapeutics's mission statement

To develop and provide best-in-class islet cell therapies for patients.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Semma Therapeutics employee reviews

Be the first to review!

Do you work at Semma Therapeutics?

Help job seekers learn about working at Semma Therapeutics

On this page

Be the first to review Semma Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Semma Therapeutics?

The team at Semma Therapeutics

  • The founders of Semma Therapeutics are Robert Millman, Semma Therapeutics, Douglas Melton and Felicia Pagliuca.
  • The key people at Semma Therapeutics are Bastiano Sanna, Robert Millman and Semma Therapeutics.
Key people
Bastiano Sanna
Robert Millman
Semma Therapeutics
Douglas Melton
Felicia Pagliuca

Semma Therapeutics rankings

Semma Therapeutics is ranked #74 on the Best Health Care companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Semma Therapeutics salaries

Average Semma Therapeutics salary
$45,255
yearly
$21.76 hourly
Updated March 14, 2024

Rate Semma Therapeutics' fairness in compensating employees.

Zippia waving zebra

Do you work at Semma Therapeutics?

Did Semma Therapeutics' compensation package meet your expectations?

Semma Therapeutics financial performance

9.8
Performance score

Are you an executive, HR leader, or brand manager at Semma Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Semma Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Semma Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Semma Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Semma Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Semma Therapeutics. The data presented on this page does not represent the view of Semma Therapeutics and its employees or that of Zippia.

Semma Therapeutics may also be known as or be related to SEMMA THERAPEUTICS, INC., Semma Therapeutics, Semma Therapeutics Inc and Semma Therapeutics, Inc.